{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T18:15:52Z","timestamp":1785867352025,"version":"3.56.0"},"reference-count":34,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2010,4,19]],"date-time":"2010-04-19T00:00:00Z","timestamp":1271635200000},"content-version":"vor","delay-in-days":1142,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Addict"],"published-print":{"date-parts":[[2007,3,4]]},"abstract":"<jats:p>In this multi\u2010center, naturalistic study, the effectiveness of naltrexone maintenance combined with the Community Reinforcement Approach (CRA) was investigated in detoxified, opioid\u2010dependent patients (N = 272). Patients were recruited from methadone maintenance programs. With intention\u2010to\u2010treat analysis, 10 months of treatment yielded abstinence rates of 28% and 32% at 10 and 16 months after detoxification. The cumulative abstinence rate at 16 months was 24%. Quality of life, craving, general psychopathology, use of other psychoactive substances, and addiction severity of the abstinent group significantly improved when compared to the relapsed group. This abstinence\u2010oriented approach appears to be a feasible goal, and remains an important option next to long\u2010term methadone maintenance in the management of opioid dependence.<\/jats:p>","DOI":"10.1080\/10550490601184472","type":"journal-article","created":{"date-parts":[[2007,5,24]],"date-time":"2007-05-24T17:59:59Z","timestamp":1180029599000},"page":"124-130","source":"Crossref","is-referenced-by-count":30,"title":["High Abstinence Rates in Heroin Addicts by a New Comprehensive Treatment Approach"],"prefix":"10.1111","volume":"16","author":[{"suffix":"MD, PhD","given":"Cor A.J.","family":"De Jong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"PhD","given":"Hendrik G.","family":"Roozen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"MA","given":"Leo G.M.","family":"Van Rossum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"PhD","given":"Paul F.M.","family":"Krabbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"PhD","given":"Ad J.F.M.","family":"Kerkhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,4,19]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2003.08.008"},{"key":"e_1_2_6_3_2","doi-asserted-by":"crossref","unstructured":"AmatoL DavoliM FerriM AliR.Methadone at tapered doses for the management of opioid withdrawal.Cochrane Database Syst Rev.2003;3:CD003409.","DOI":"10.1002\/14651858.CD003409.pub2"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.164.3.277"},{"key":"e_1_2_6_5_2","volume-title":"Detoxification: Principles and Protocols","author":"Kasser C","year":"1997"},{"key":"e_1_2_6_6_2","first-page":"CD002022","article-title":"(2002) Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal","volume":"2","author":"Gowing L","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_6_7_2","first-page":"CD001333","article-title":"Naltrexone maintenance treatment for opioid dependence","volume":"3","author":"Kirchmayer U","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"e_1_2_6_8_2","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1080\/10550490390210083","article-title":"Pharmacologic treatments for heroin and cocaine dependence","volume":"12","author":"Kleber HD","year":"2003","journal-title":"Am J Addict"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1159\/000068808"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2004.00884.x"},{"key":"e_1_2_6_11_2","volume-title":"Clinical Guide to Alcohol Treatment: The Community Reinforcement Approach","author":"Meyers RJ","year":"1995"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2003.12.006"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2004.00959.x"},{"key":"e_1_2_6_14_2","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1994"},{"key":"e_1_2_6_15_2","volume-title":"EDOCRA: handleiding CRA","author":"Roozen HG","year":"2000"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1159\/000259089"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-199206000-00002"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8510(96)00822-6"},{"key":"e_1_2_6_19_2","volume-title":"SCL\u201090\u2010R: Administration, Scoring and Procedures. Manual II","author":"Derogatis LR","year":"1983"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0740-5472(99)00050-1"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(02)00077-7"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.58.8.755"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.279.3.229"},{"key":"e_1_2_6_24_2","first-page":"CD002021","article-title":"Opioid antagonists with minimal sedation for opioid withdrawal","volume":"2","author":"Gowing L","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1300\/J069v19n02_02"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(02)00326-5"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(98)00100-8"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-6576.2000.440319.x"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0899-3289(00)00019-5"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(97)00073-2"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1176\/ps.49.6.831"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1080\/10550490252801639"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2005.06.003"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7410.310"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2004.00785.x"}],"container-title":["The American Journal on Addictions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1080%2F10550490601184472","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1080\/10550490601184472","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T21:11:50Z","timestamp":1698786710000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1080\/10550490601184472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3,4]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,3,4]]}},"alternative-id":["10.1080\/10550490601184472"],"URL":"https:\/\/doi.org\/10.1080\/10550490601184472","archive":["Portico"],"relation":{},"ISSN":["1055-0496","1521-0391"],"issn-type":[{"value":"1055-0496","type":"print"},{"value":"1521-0391","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3,4]]}}}